Novartis Investigative Site

Vinnitsa 21018

0 studies enrolling now · 2 studies all time

What they study most

Leukaemia, Lymphocytic, Chronic

Studies at this site

• Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia — Completed
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early